Trial Profile
Effect of Neuromuscular Blockade on Surgical Conditions and Patient Reported Comfort Scores in Total Hip Replacement Arthroplasty
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 14 Mar 2019
Price :
$35
*
At a glance
- Drugs Rocuronium bromide (Primary) ; Sugammadex (Primary)
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 11 Mar 2019 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 19 Dec 2017 New trial record